Annual ROE
-40.49%
-4.08%-11.21%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual return on equity is -40.49%, with the most recent change of -4.08% (-11.21%) on December 31, 2023.
- During the last 3 years, TNGX annual ROE has risen by +94.15% (+69.93%).
- TNGX annual ROE is now -33.28% below its all-time high of -30.38%, reached on December 31, 2021.
Performance
TNGX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-48.54%
-2.12%-4.57%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly return on equity is -48.54%, with the most recent change of -2.12% (-4.57%) on September 30, 2024.
- Over the past year, TNGX quarterly ROE has dropped by -6.82% (-16.35%).
- TNGX quarterly ROE is now -117.67% below its all-time high of -22.30%, reached on September 30, 2021.
Performance
TNGX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TNGX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -16.4% |
| 3 y3 years | +69.9% | -19.7% |
| 5 y5 years | +69.9% | -19.7% |
TNGX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.3% | at low | -108.1% | at low |
| 5 y | 5-year | -33.3% | +69.9% | -117.7% | +64.2% |
| alltime | all time | -33.3% | +69.9% | -117.7% | +64.2% |
Tango Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -48.54%(+4.6%) |
| Jun 2024 | - | -46.42%(+2.6%) |
| Mar 2024 | - | -45.23%(+8.4%) |
| Dec 2023 | -40.49%(+11.2%) | -41.72%(+3.4%) |
| Sep 2023 | - | -40.36%(-4.7%) |
| Jun 2023 | - | -42.34%(+4.4%) |
| Mar 2023 | - | -40.54%(+11.4%) |
| Dec 2022 | -36.41% | -36.39%(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -31.57%(-5.8%) |
| Jun 2022 | - | -33.52%(+25.6%) |
| Mar 2022 | - | -26.69%(+14.4%) |
| Dec 2021 | -30.38%(-77.4%) | -23.33%(+4.6%) |
| Sep 2021 | - | -22.30%(-83.5%) |
| Jun 2021 | - | -135.40%(+9.4%) |
| Mar 2021 | - | -123.76%(+33.9%) |
| Dec 2020 | -134.64% | -92.40% |
FAQ
- What is Tango Therapeutics annual return on equity?
- What is the all time high annual ROE for Tango Therapeutics?
- What is Tango Therapeutics annual ROE year-on-year change?
- What is Tango Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Tango Therapeutics?
- What is Tango Therapeutics quarterly ROE year-on-year change?
What is Tango Therapeutics annual return on equity?
The current annual ROE of TNGX is -40.49%
What is the all time high annual ROE for Tango Therapeutics?
Tango Therapeutics all-time high annual return on equity is -30.38%
What is Tango Therapeutics annual ROE year-on-year change?
Over the past year, TNGX annual return on equity has changed by -4.08% (-11.21%)
What is Tango Therapeutics quarterly return on equity?
The current quarterly ROE of TNGX is -48.54%
What is the all time high quarterly ROE for Tango Therapeutics?
Tango Therapeutics all-time high quarterly return on equity is -22.30%
What is Tango Therapeutics quarterly ROE year-on-year change?
Over the past year, TNGX quarterly return on equity has changed by -6.82% (-16.35%)